VACDIVA – A safe DIVA vaccine for African Swine Fever control and eradication

African swine fever (ASF) is a devastating infectious disease in pigs – usually deadly. No vaccine exists to combat this virus. The European Union has laid down prevention and control measures to be applied where African swine fever is suspected or confirmed, either in holdings or in wild boars.
The EU-funded VACDIVA project aims to provide three safe and effective pilot vaccines for wild boar and domestic pigs that is ready for registration. It also validates tests and developes cost-benefit and -effective surveillance and control-vaccination strategies.

Details

Status:

  • inactive

Research Focus:

  • Medicine and Health

Project Coordination:

Universidad Complutense De Madrid
(UCM)

Partners:

Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain
Gold Standard Diagnostics Madrid, Spain
HORIZCIENCE SL, Spain
Allatorvostudomanyi Kutatointezet, Hungary
Nemzeti Elelmiszerlanc-Biztonsagi Hivatal, Hungary
China Animal Health And Epidemiology Center, China
Institute Of Animal Science (Ias), Chinese Academy Of Agricultural Sciences (Caas), China
European Coordination Via Campesina, Belgium
Faculdade De Medicina Veterinaria, Portugal
Fgi Federal Centre For Animal Health, Russia
Intervet International Bv, Netherlands
Stichting Wageningen Research, Netherlands
Istituto Zooprofilattico Sperimentale Dell’umbria E Delle Marche, Italy
Istituto Zooprofilattico Sperimentale Della Sardegna G. Pegreffi, Italy
Nacionalinis Maisto Ir Veterinarijos Rizikos Vertinimo Institutas, Lithuania
Partikas Drosibas, Dzivnieku Veselibas Un Vides Zinatniskais Institutsbior, Latvia
Riigi Laboriuuringute Ja Riskihindamise Keskus, Estonia
Statni Veterinarni Ustav Jihlava, Czechia

Countries:

Germany (Bavaria), Kenya

Funding Agency:

European Union (EU)

Funding Type:

H2020

Duration:

01/10/2019
– 31/12/2024

Budget:

9168652 EUR

URL: